The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588Massimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|Microorganisms|2024Cited by 15
The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-RadiotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|International Journal of Molecular Sciences|2024Cited by 13
Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Francesco Di Pierro et al.|Pathology & Oncology Research|2023Cited by 9
Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled TrialAlexander Bertuccioli, Davide Sisti, Marco Cardinali et al.|Microorganisms|2024Cited by 8
Clostridium butyricum Strain MIYAIRI 588 (CBM588) as a Precision Probiotic Therapy in the Ketogenic Diet: A Possible Application?Alexander Bertuccioli, Francesco Di Pierro, Marco Cardinali et al.|Microbiology Research|2023Cited by 7